Catalyst Wire Dossier Catalyst Wire Dossier

Cedazuridine-Decitabine

cedazuridine-decitabine
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Cedazuridine-Decitabine, covering 2026-04-24 to 2026-07-17. Get the full timeline:

Most recent: EMA Authorised: Inaqovi (cedazuridine;decitabine) — Otsuka Pharmaceutical Netherlands B.V.

See pricing